By Lauren Slater / Source: NY Times
Pam Sakuda was 55 when she found out she was dying. Shortly after having a tumor removed from her colon, she heard the doctor's dreaded words: Stage 4; metastatic.
Sakuda was given 6 to 14 months to live. Determined to slow her disease's insidious course, she ran several miles every day, even during her grueling treatment regimens.
By nature upbeat, articulate and dignified, Sakuda — who died in November 2006, outlasting everyone's expectations by living for four years — was alarmed when anxiety and depression came to claim her after she passed the 14-month mark, her days darkening as she grew closer to her biological demise.
Norbert Litzinger, Sakuda's husband, explained it this way: "When you pass your own death sentence by, you start to wonder:
When? When? It got to the point where we couldn't make even the most mundane plans, because we didn't know if Pam would still be alive at that time — a concert, dinner with friends; would she still be here for that?"
When came to claim the couple's life completely, their anxiety building as they waited for the final day.
As her fears intensified, Sakuda learned of
a study being conducted by Charles Grob, a psychiatrist and researcher at Harbor-U.C.L.A. Medical Center who was administering psilocybin — an active component of magic mushrooms — to end-stage cancer patients to see if it could reduce their fear of death.
